Ram Lakshmanan, M.D.
Ram Lakshmanan, M.D. has dedicated himself to treating patients for 29 years in community private practice full-time, across a broad range of psychiatric disorders including depression, anxiety, attention deficient disorders (ADHD/ADD), bipolar disorders and substance abuse disorders, including alcohol and nicotine addiction. He is known for running one of the most ethical practices in the community and devising treatment plans tailored to individual patients to drive towards optimal patient outcomes. He is up to date with the state of the art treatments in psychiatry, having recently passed the Addiction Psychiatry board certification exam in April 2019. He is also a specialist in Suboxone treatment for pain pill addiction.
His approach involves thorough Psychiatry history intake, evaluation and administering patient questionnaires, in order to arrive at a specific diagnosis, to form the foundation of devising a patient-specific treatment plan. The diagnoses and treatment plans are developed through pursuing current evidence-based approaches and understanding patients’ unique personal goals because he believes in treating the patient holistically, including physical, psychological, social and spiritual wellness. He helps patients reach their goals by closely tracking the patient’s progress, target symptoms, and continuously reviewing and updating the treatment plan in subsequent visits.
He is an accomplished hiker, having ascended to the summit of Mount Kilimanjaro (19,341 ft elevation gain) in February 2019. He has also hiked to Evert base camp (17,000 ft elevation gain) and Mt Kailash (18,200 ft elevation gain) at the Tibet/China border. He regularly runs in Houston’s Chevron/Aramco Half Marathon. In his down-time he enjoys gardening and reading.
Dr. Lakshmanan is a diplomate of the American Board of Psychiatry and Neurology,Inc. (ABPN) and board certified in General and Addiction Psychiatry by ABPN. He received his residency training at the Rosalind Franklin University in North Chicago, IL from 1987-1990. He has interest in treating Opioid Disorders with Suboxone,, Alcohol dependence disorders with Naltrexone and Campral, and Cigarette smoking with Chantix and Bupropion medications. He recently passed the re-certification board exam in Addiction Psychiatry in April 2019 by ABPN. He is also Board certified in Addiction Medicine by American Society of Addiction Medicine (ASAM). He is a Fellow of American Psychiatric Association APA, a member of American Academy of Addiction Psychiatry (AAAP) and a member of Texas Society of Psychiatric Association.